Gordon Hughes, MD
Rheumatology · Elkhart, INNPI 1003895681
Payments from drug & device makers
Across 594 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- AbbVie$2K
- Johnson & Johnson$1K
- UCB, Inc.$856
- Mallinckrodt Hospital Products Inc.$477
- Novartis$470
- plus $4K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 119 | $2,559 |
| AbbVie | 147 | $2,307 |
| Johnson & Johnson(2 entities) | 55 | $1,125 |
| UCB, Inc. | 43 | $856 |
| Mallinckrodt Hospital Products Inc. | 17 | $477 |
| Novartis | 24 | $470 |
| Lilly USA, LLC | 19 | $457 |
| Pfizer | 28 | $455 |
| GSK | 27 | $404 |
| E.r. Squibb & Sons, L.L.C. | 17 | $378 |
| Genentech USA, Inc. | 10 | $266 |
| Pacira Therapeutics, Inc. | 10 | $235 |
| AstraZeneca | 12 | $215 |
| Ferring Pharmaceuticals Inc. | 8 | $165 |
| Merck | 9 | $145 |
| Aurinia Pharma U.S., Inc. | 7 | $134 |
| Radius Health, Inc. | 7 | $122 |
| Bristol Myers Squibb | 4 | $92 |
| Mallinckrodt Enterprises LLC | 4 | $90 |
| Boehringer Ingelheim | 4 | $89 |
| ANI Pharmaceuticals, Inc. | 3 | $75 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Sanofi | 2 | $49 |
| Novo Nordisk | 2 | $34 |
| Actelion Pharmaceuticals US, Inc. | 2 | $30 |
| Sobi, Inc | 1 | $23 |
| Adaptive Biotechnologies Corporation | 1 | $23 |
| Zimmer Biomet | 1 | $23 |
| Bioventus LLC | 1 | $22 |
| Fidia Pharma USA Inc. | 1 | $21 |
| Scilex Pharmaceuticals Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Sandoz | 1 | $19 |
| Incyte Corporation | 1 | $18 |
| Nevro Corp. | 1 | $16 |
| Gilead | 1 | $14 |
How this compares
$11,513 in reported general payments places this provider in the 80th percentile of 106 rheumatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Elkhart
- Moges SisayEvansville$1.8M
- David BattIndianapolis$577K
- Kathleen ThomasNoblesville$511K
- Keith ReichDyer$193K
- Douglas SmithIndianapolis$147K
- Ahmad SalahMerrillville$139K
- Inna AroutiounovaIndianapolis$102K
- James CohenIndianapolis$76K
- Nina RamessarFort Wayne$75K
- Steven HugenbergIndianapolis$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.